Fill in your inscription today and join the Charcot Team during the 20km off Brussels on May 19, 2019. It will be a perfect day and you will be helping the MS-Research.
13 500 patients are counting on this research and thank you.
The two major research pathways that could change the future of people with multiple sclerosis, confirm themselves and a life where MS becomes a treatable and controllable condition comes a step closer.
A precise description of the clinical subtypes of multiple sclerosis is necessary in order to better classify each patient’s disease and better tailor their immunomodulatory therapy according to its course.
Why does a person with a particular predisposition due to hereditary genetic factors develop the disease at all? Lies Van Horebeek proposes a novel explanation in her research project...
In recent years, it has been shown that starting treatment early in MS patients significantly improves the long-term prognosis in the relapsing-remitting forms. It is therefore critically important that MS be diagnosed as soon as possible ...
